Targeting Angiopoietin-2 in DME: Efficacy and Safety Data With Drs. Carl Regillo and Nancy Holekamp

The angiopoietin/Tie2 pathway is an attractive therapeutic target for the management of retinal and choroidal vascular diseases, as it has been identified to play a role in vascular permeability and angiogenesis within the eye. Several therapies targeting this pathway have been investigated, and the FDA recently approved the first agent that inhibits both the angiopoietin-2 (Ang-2) and vascular endothelial growth factor (VEGF)-A pathways for the treatment of neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME). Dual inhibition of these 2 pathways has the potential to enhance visual acuity outcomes while lowering the treatment burden. In this podcast, Dr. Carl Regillo and Dr. Nancy Holekamp discuss the efficacy and safety of therapies targeting Ang-2 in DME.

Episode metadata supplied by the publisher feed · Published May 31, 2022

NOW PLAYING

0:00 16:41

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

Research Reimagined: The AI Advantage

Jul 2, 2026 ·25m

When Sustainability Meets Surgery

Jun 24, 2026 ·29m

Vision Through Music

Jun 17, 2026 ·27m

Stop Asking Insurance for Permission: The Refractive Mindset

Jun 10, 2026 ·40m

Jordana Goren Fein, MD, MS - Bringing Retinal Vein Occlusion Into Focus: Case-Based Approaches to Optimizing Management With Anti-VEGF Therapies

Jun 5, 2026 ·22m

Amanda Turner: Building Onboarding Around the Patient Journey

Jun 5, 2026 ·32m

Similar Podcasts

Success Confidentials The Patient Whisperers 🎙️ UPDATE: We’ve taken a little break to focus on the learning content you've asked for in our app. Please enjoy a few of our favorite past episodes. We’ll be back!Join us for Success Confidentials – conversations that challenge the way we do healthcare. Christine and Lauren share what made their own practice wildly successful.If you are a visionary Eye Care, Ophthalmology, Optometry, Aesthetics or Premium Concierge Medicine practice owner, leader or marketer, you're in the right place. The Ophthalmology Experience with Guido Piquet Boost Patients Welcome to The Ophthalmology Experience, where we discuss the business side of Ophthalmology. Hosted by Guido Piquet, the Chief Operations Officer of Mann Eye Institute, this podcast features conversations with industry leaders, practice administrators, and physicians about the challenges of running and growing successful practices.With almost two decades in Ophthalmology, Guido brings practical advice, real stories, and strategies on leadership, patient acquisition, and the latest technologies shaping the industry.The Ophthalmology Experience is produced and powered by Boost Patients. Dr Nima's Eye Pod Nima Ghadiri Podcast for my videos and shorts on medicine, ophthalmology, technology and uveitis which are also available on other media Youtube: https://www.youtube.com/@drnimaeye/featured Instagram: https://www.instagram.com/drnimaeye/ TikTok: https://www.tiktok.com/@drnimaeye Let’s Talk Ophthalmology: an Evolve Medical Education Podcast Evolve Medical Education, LLC This podcast features content for the modern ophthalmologists, including topics such as cataract and refractive surgery, glaucoma, and retinal disease, among others. Evolve’s podcasts help today's ophthalmologists stay current on important topics in an easy-to-access, on-demand format.

Frequently Asked Questions

How long is this episode of MedEdTalks - Ophthalmology?

This episode is 16 minutes long.

When was this MedEdTalks - Ophthalmology episode published?

This episode was published on May 31, 2022.

What is this episode about?

Can I download this MedEdTalks - Ophthalmology episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.

URL copied to clipboard!